# K062809: Admiral Xtreme Pta Catheter

- Pathway: 510(k) (Special)
- Applicant: Invatec Innovative Technologies
- Decided: Oct 18, 2006 after 29 days
- Product code: DQY (Catheter, Percutaneous)
- Device class: 2
- Regulation: 21 CFR 870.1250
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K042538 (2004). 1 ancestor in all.
53 later devices descend from it; 5 cite it directly.
0 of 55 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K042538: Sailor Plus Percutaneous Transluminal Angioplasty (Pta) Catheter, Model Saexxxxxxxxx, Invatec Innovative Technologies (2004) Summary page 1.

## Most influential descendants
- K082579: Evercross .035 Otw Pta Dilatation Catheter (2008), 35 descendants of its own
- K093286: Powercross .018 Otw Pta Dilation Catheter (2009), 14 descendants of its own
- K100921: Admiral Xtreme Pta Balloon Dilatation Catheter (2010), 12 descendants of its own
- K103464: Pacific Xtreme Ptca Balloon Dilatation Catheter (2010), 9 descendants of its own
- K123544: Rapidcross Pta Rapid Exchange, Balloon Dilatation Catheter (2013), 8 descendants of its own

## Indications for use
The ADMIRAL XTREME MT PTA Balloon Dilatation Catheter is intended to dilate stenoses in the iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Source page: https://510kreport.com/device/K062809
Methodology: https://510kreport.com/methodology